2ZE-14311-32387
3 vaccinations
10 coded responses
32 check-ins
10 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 51-55
- ZIP prefix
- 852 / AZ
- Registered
- 2020-12-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
N2T-19414-39854
Child or adolescent in my care · Female · 2021-11-06
Timeline
-
2020-12-26
Registered in v-safe
-
2020-12-26
Dose 1 — Pfizer-BioNTech
-
2020-12-26
Survey response — day 0, dose 1MedDRA: Asthma, COVID-19, Dyspnoea exertional, Fatigue — Feeling: Fair · Fatigue or tirednessFree text: I had COVID-19 on 11/18/2020. Still tired with SOB on exertion. Also have had asthma flare x 1 weekMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-27
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2020-12-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-01-01
- 2021-01-03
- 2021-01-09
- 2021-01-16
-
2021-01-20
Dose 2 — Pfizer-BioNTech
-
2021-01-23
Survey response — days 1–6 daily, dose 2MedDRA: Wheezing — Feeling: Good · Site: PainFree text: WheezingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-24
- 2021-01-26
- 2021-01-27
-
2021-02-03
Survey response — day 14, dose 2MedDRA: Asthma, Hypersensitivity, Pre-existing disease — Feeling: GoodFree text: My asthma is acting up along with my allergies.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-10
- 2021-02-17
-
2021-02-24
Survey response — day 35, dose 2MedDRA: Asthma, Hypersensitivity, Pre-existing disease — Feeling: FairFree text: My asthma is flaring and my allergies are too.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-03
- 2021-04-23
- 2021-07-21
-
2021-10-01
Dose 3 — Pfizer-BioNTech
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Pyrexia — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolFree text: Temps to 102.5 day after Pfizer #3 and 101 2nd day after and all same sx.as aboveMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Chills, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-10-07
- 2021-10-08
-
2021-10-15
Survey response — day 14, dose 3MedDRA: Condition aggravated, Fatigue, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Worsening focus and increased fatigueMedDRA releases: 2024-11 · check-in free text available
-
2021-10-22
Survey response — day 21, dose 3MedDRA: Brain fog, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: More fatigue and brain fogMedDRA releases: 2024-11 · check-in free text available
-
2021-10-29
Survey response — day 28, dose 3MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: FatigueMedDRA releases: 2024-11 · check-in free text available
- 2021-11-05
-
2021-11-12
Survey response — day 42, dose 3MedDRA: Fatigue, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Fatigue, focusMedDRA releases: 2024-11 · check-in free text available
-
2021-12-31
Survey response — 3 months, dose 3MedDRA: Exposure to SARS-CoV-2, Oropharyngeal pain, SARS-CoV-2 test — Feeling: Fair · Be unable to work or attend schoolFree text: Sore throat. Exposed to someone with COVID early this week. Awaiting PCR test from yestMedDRA releases: 2024-11 · check-in free text available
- 2022-04-01
- 2022-10-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-26 | Pfizer-BioNTech | |
| 2 | 2021-01-20 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): I had COVID-19 on 11/18/2020. Still tired with SOB on exertion. Also have had asthma flare x 1 week
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Wheezing
Release 3 — day 14, dose 2
Symptoms: My asthma is acting up along with my allergies.
Release 4 — day 35, dose 2
Symptoms: My asthma is flaring and my allergies are too.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Temps to 102.5 day after Pfizer #3 and 101 2nd day after and all same sx.as above
Release 10 — day 14, dose 3
Symptoms: Worsening focus and increased fatigue
Release 10 — day 21, dose 3
Symptoms: More fatigue and brain fog
Release 10 — day 28, dose 3
Symptoms: Fatigue
Release 10 — day 42, dose 3
Symptoms: Fatigue, focus
Release 10 — 3 months, dose 3
Symptoms: Sore throat. Exposed to someone with COVID early this week. Awaiting PCR test from yest
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Asthma | ✓ | ✓ | ✓ |
| SRO | COVID-19 | ✓ | ✓ | ✓ |
| SRO | Dyspnoea exertional | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Pyrexia | · | · | ✓ |
| SRO | Wheezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release